Skip to main content

Squarepoint Ops LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in AXSM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$37,842,665
+$18,557,145 QoQ
Shares Held
154,605
+35.5% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#59
of 494 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in AXSM Over Time

Shares Held

Position Value (USD)

Derivatives in AXSM

reported options exposure · as of Jun 30, 2026
CallValue
$269,247
CallShares
1,100
PutValue
$220,293
PutShares
900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,789,234 across 255 Biotechnology names. AXSM ranks #8 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 AXSM
Axsome Therapeutics, Inc.
This page
154,605 $37,842,665

All Filings in AXSM

Export CSV
29 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $220,293 900
2026-06-30 $269,247 1,100
2026-06-30 $37,842,665 154,605
2026-03-31 $19,285,520 114,102
2026-03-31 $236,628 1,400
2025-12-31 $529,656 2,900
2025-12-31 $237,432 1,300
2025-12-31 $28,309,200 155,000
2025-09-30 $340,060 2,800
2025-09-30 $18,824,750 155,000
2025-06-30 $17,015,570 163,000
2025-06-30 $292,292 2,800
2025-03-31 $1,924,395 16,500
2025-03-31 $16,514,458 141,597
2025-03-31 $1,072,996 9,200
2024-12-31 $600,731 7,100
2024-12-31 $1,133,774 13,400
2024-12-31 $7,566,672 89,430
2024-09-30 $844,778 9,400
2024-09-30 $943,635 10,500
2023-12-31 $202,954 2,550
2023-09-30 $6,762,626 96,761
2022-12-31 $3,441,232 44,616
2022-09-30 $5,916,299 132,593
2022-06-30 $321,375 8,391
2021-09-30 $353,660 10,730
2021-06-30 $1,484,322 22,003
2021-03-31 $709,391 12,529
2020-03-31 $1,072,706 18,234